The following trials provide information to treat various types of disease of the brain and the central and local nervous systems, both for ongoing and completed clinical trials. For more information on this therapy area please click here.
- collapse A Double-blind, Randomized, 2-Period Crossover Study to Compare the Safety and Tolerability of a Titration of Sustained Release Formulation Quetiapine Fumarate (SEROQUEL) with Placebo in Healthy Volunteers
- collapse A Double blind, Randomized, 2-Period Crossover Study to Compare the Tolerance and Safety of Sustained Release Formulation Quetiapine Fumarate (SEROQUEL) with Placebo in Healthy Volunteers
- collapse A 6-week, Double-blind, Randomized, Parallel-group, International, Multi-center, Phase III Study Comparing the Efficacy and Safety of Sustained-Release and Immediate-Release Quetiapine Fumarate (SEROQUEL) to PLacebo in the Treatment of Agitation Associated with Alzheimer's Dementia in Elderly Residents of Long-term Care Facilities.
- collapse A Phase I, Randomized, Double-Blind, Parallel Group, Multi-Center Study to Compare the Safety and Tolerability of Two Titration Schemes for Sustained-Release Quetiapine Fumarate with a Constant-Dose Scheme of Sustained-Release Quetiapine Fumarate in Schizophrenic and Schizoaffective Patients
- collapse A Study to Compare the Pharmacokinetics of 50 mg and 300 mg Quetiapine fumarate SR Tablets Administered following a Light Meal and in the Fasted State in Adult Volunteers and Adults with Schizophrenia, Schizoaffective Disorder or Bipolar Disorder
- collapse Phase I Randomized, Open Label 5- Treatment Study
- collapse Quetiapine bioequivalence study_Austria_Local
- collapse Driving ability under Quetiapine
- collapse UK SMS Study
- collapse Efficacy & Safety in Rapid Titration Manic Bipolar Disorder
